Trial Outcomes & Findings for Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence (NCT NCT03021759)
NCT ID: NCT03021759
Last Updated: 2019-06-20
Results Overview
Percentage of patients eligible for a statin that have been prescribed a statin
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
4774 participants
Primary outcome timeframe
Two Months
Results posted on
2019-06-20
Participant Flow
No informed consent was obtained from the participants in this study.
Participant milestones
| Measure |
Control
No intervention
|
Active Choice
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin.
Active choice: Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin
|
Active Choice With Social Comparison Feedback
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers
Active choice: Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin.
Social comparison feedback: Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers
|
|---|---|---|---|
|
Overall Study
STARTED
|
1566
|
1743
|
1465
|
|
Overall Study
COMPLETED
|
1566
|
1743
|
1465
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Baseline characteristics by cohort
| Measure |
Control
n=1566 Participants
No intervention
|
Active Choice
n=1743 Participants
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin.
Active choice: Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin
|
Active Choice With Social Comparison Feedback
n=1465 Participants
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers
Active choice: Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin
Social comparison feedback: Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers
|
Total
n=4774 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
62.1 years
STANDARD_DEVIATION 8.5 • n=5 Participants
|
62.4 years
STANDARD_DEVIATION 8.2 • n=7 Participants
|
62.5 years
STANDARD_DEVIATION 8.2 • n=5 Participants
|
62.4 years
STANDARD_DEVIATION 8.3 • n=4 Participants
|
|
Sex: Female, Male
Female
|
738 Participants
n=5 Participants
|
710 Participants
n=7 Participants
|
701 Participants
n=5 Participants
|
2149 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
828 Participants
n=5 Participants
|
1033 Participants
n=7 Participants
|
764 Participants
n=5 Participants
|
2625 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
White non-Hispanic
|
1004 Participants
n=5 Participants
|
1110 Participants
n=7 Participants
|
926 Participants
n=5 Participants
|
3040 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Black non-Hispanic
|
420 Participants
n=5 Participants
|
479 Participants
n=7 Participants
|
419 Participants
n=5 Participants
|
1318 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Other
|
142 Participants
n=5 Participants
|
154 Participants
n=7 Participants
|
120 Participants
n=5 Participants
|
416 Participants
n=4 Participants
|
|
Annual Household Income
<50,000 US$
|
435 Participants
n=5 Participants
|
563 Participants
n=7 Participants
|
406 Participants
n=5 Participants
|
1404 Participants
n=4 Participants
|
|
Annual Household Income
50,000 - 100,000 US$
|
784 Participants
n=5 Participants
|
960 Participants
n=7 Participants
|
733 Participants
n=5 Participants
|
2477 Participants
n=4 Participants
|
|
Annual Household Income
>100,000 US$
|
341 Participants
n=5 Participants
|
206 Participants
n=7 Participants
|
312 Participants
n=5 Participants
|
859 Participants
n=4 Participants
|
|
Annual Household Income
Missing
|
6 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
34 Participants
n=4 Participants
|
PRIMARY outcome
Timeframe: Two MonthsPercentage of patients eligible for a statin that have been prescribed a statin
Outcome measures
| Measure |
Control
n=1566 Participants
No intervention
|
Active Choice
n=1743 Participants
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin.
Active choice: Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin
|
Active Choice With Social Comparison Feedback
n=1465 Participants
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers
Active choice: Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin
Social comparison feedback: Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers
|
|---|---|---|---|
|
Statin Prescribing Rate
|
40 Participants
|
116 Participants
|
117 Participants
|
Adverse Events
Control
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Active Choice
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Active Choice With Social Comparison Feedback
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place